[ad_1]
21 minutes ago
Remdesivir
The World Health Organization announced on Friday that the United States allowed the use of the drug “remdesivir” to treat patients with Corona, did not take into account the results of the organization’s trials with the drug.
The organization’s chief expert, Sumaya Swaminathan, said that the US authorities’ approval to use the drug “remdesivir” to treat Corona was based on data from the company “Gilead” that manufactured the drug, and that “apparently , the results of the “solidarity” experiment before the license were not reviewed.
The “Solidarity” experiment is an international clinical trial launched by the World Health Organization and its partners to find an effective treatment for “Covid-19”.
Yesterday, the US Drug Agency issued a license to use the drug “Remdisiver” to treat Corona patients in hospitals, after granting a conditional authorization for its use in May.
Yesterday, the US Drug Agency issued a license to use the drug “Remdesivir” to treat Corona patients in hospitals, after granting conditional authorization for its use in May.
Following the announcement, the share of Gilead, which makes the drug on the New York Stock Exchange, rose 4 percent.
And “remdesivir” is one of the first drugs to show relative effectiveness during rigorous trials in reducing the number of days required for recovery for “Covid-19” patients in hospitals.
Other properties were licensed for months, but only for emergency use.
With the end of the health emergency, these licenses, which were granted based on incomplete databases, could be revoked.
Since spring, Europe and other countries have allowed the temporary use of “remdesivir.”
The drug can be administered to people over twelve years of age and weighing 40 kg, provided they are in hospitals or in a similar environment.
US President Donald Trump was dosed with the drug for five days when he contracted Corona in early October.
